Clarivate's Q3 2026 Continuing-Operations Organic Revenue Rises 0.4%

The Tip Desk · November 10, 2026 · 3 min read

Third-quarter 2026 continuing-operations revenue was $481.6 million as organic revenue rose 0.4%. Including LS&H, adjusted net income was $136.0 million, while net loss widened to $80.8 million, driven by a $62.2 million non-cash LS&H goodwill impairment charge.

Clarivate Plc (CLVT), a global provider of intelligence products for academia, government and intellectual property, reported continuing-operations revenue of $481.6 million and organic revenue growth of 0.4% for the third quarter ended September 30, 2026. Net loss including LS&H widened to $80.8 million from $28.3 million a year earlier, driven by a $62.2 million non-cash LS&H goodwill impairment charge.

Total revenues including the Life Sciences & Healthcare segment were $567.9 million, compared with $623.1 million a year earlier, primarily due to inorganic disposals. Excluding LS&H, which is now presented as discontinued operations, revenues were $481.6 million, versus $530.3 million a year earlier.

Organic subscription growth of 1.5% and organic re-occurring growth of 0.7% more than offset lower organic transactional revenues. Subscription revenues were $338.3 million. Re-occurring revenues were $105.8 million. Recurring revenues, which consist of subscription and re-occurring revenues, increased 1.3% organically, or $5.7 million.

Transactional revenues decreased $51.6 million to $37.5 million, primarily due to product group wind-downs within Academia & Government. On an organic basis, the decline was 12.4%, or $3.9 million, which the company said was driven in part by customer migration to higher-margin subscription products as it focuses on recurring revenues.

Organic ACV for continuing operations grew 1.8% compared with September 30, 2025. The company said organic ACV growth was primarily driven by improved product pricing.

Academia & Government revenues were $286.9 million. Intellectual Property revenues were $194.7 million.

Net loss including LS&H was $80.8 million, or $0.13 a share, compared with a net loss of $28.3 million, or $0.04 a share, a year earlier, driven by a $62.2 million non-cash LS&H goodwill impairment charge. Adjusted net income including LS&H was $136.0 million, or $0.21 a share, compared with $119.3 million, or $0.18 a share, a year earlier. Adjusted EBITDA including LS&H was $245.3 million. Adjusted EBITDA for continuing operations was $218.2 million, and the adjusted EBITDA margin for continuing operations was 45.3%.

On October 6, 2026, the company completed the sale of LS&H for net cash proceeds of $488.4 million. Chief Executive Officer Matti Shem Tov said the early close positioned the company for enhanced value creation in Academia & Government and Intellectual Property and cited commercial traction from AI-led innovation in those segments.

Cash and cash equivalents were $257.0 million as of September 30, 2026. Total debt outstanding was $4,176.1 million, down $293.8 million from the prior year, after a $100.0 million accelerated repayment in January 2026 that fully redeemed the senior secured notes due November 2026 and the retirement of $192.6 million of senior secured notes due 2028 and senior notes due 2029 through repurchases at an approximate 5% discount to par.

The company updated its 2026 outlook, with full-year forecasts including discontinued-operations results for the nine months ended September 30, 2026, and excluding them for the fourth quarter. Full-year 2026 recurring organic revenue growth is now 1.00% to 1.50%. Fourth-quarter 2026 recurring organic revenue growth is guided at 2.00% to 2.50%. Full-year revenues are expected at $1.965 billion to $1.985 billion, with adjusted EBITDA of $0.865 billion to $0.885 billion and adjusted diluted EPS of $0.73 to $0.77. Fourth-quarter revenues are expected at $490 million to $510 million, with adjusted EBITDA of $215 million to $235 million and adjusted diluted EPS of $0.14 to $0.18. Free cash flow for the full year is expected at $320 million to $340 million, and $85 million to $105 million in the fourth quarter. The outlook assumes no further acquisitions, divestitures, or unanticipated events.